Note: This article is for general information. Treatment doses for vitamin D deficiency depend on laboratory results, age, absorption, kidney and liver function, pregnancy, bone health, and medicines. Do not change prescribed high-dose treatment based on this article.

What does vitamin D do?

Vitamin D supports intestinal absorption of calcium and phosphate, bone mineralisation, and muscle function. Skin can make vitamin D through UVB exposure; oily fish, egg yolk, and fortified foods are dietary sources. Production varies greatly with season, latitude, clothing, skin pigmentation, age, and time outdoors.

North American reference intakes are 600 IU (15 micrograms) for most adults and 800 IU (20 micrograms) after age 70. These values are population reference intakes, not treatment doses for confirmed deficiency. Nutrition policy and clinical guidelines may use different targets across countries.

Who is more likely to need supplementation?

Confirmed deficiency; osteoporosis or fragility fracture; reduced absorption from coeliac disease, inflammatory bowel disease, or bariatric surgery; very limited sun and dietary sources; selected liver or kidney diseases; and medicines affecting vitamin D metabolism warrant closer assessment.

The 2024 Endocrine Society guideline advises against routine supplementation above recommended intake and against routine 25(OH)D testing in healthy adults under 50 for disease prevention, with a similar approach for healthy adults aged 50–74. It gives conditional empiric supplementation suggestions for adults over 75, pregnancy, and selected people with high-risk prediabetes; dose and expected benefit differ by group.

FigureThe supplementation decision is not the same for everyone
Usually unnecessary

Healthy, low-risk adult

Assess reference intake and diet rather than routine testing or high doses.

Assess further

Risk factor or symptom

History, diet, medicines, and when appropriate 25(OH)D are interpreted together.

Treatment plan

Confirmed deficiency

Dose, duration, underlying cause, and follow-up are individualized.

Closer supervision

Kidney, parathyroid, or absorption disorder

A standard over-the-counter approach may be inappropriate.

A population guideline does not replace treatment decisions for an individual with deficiency.

Should everyone have a vitamin D test?

The main test for vitamin D status is serum 25-hydroxyvitamin D, or 25(OH)D. The active hormone, 1,25-dihydroxyvitamin D, is not the appropriate routine measure of stores and can be normal or high in some conditions.

Screening every healthy low-risk person has not been shown to improve health outcomes, and there is no complete international agreement on one perfect threshold. A result should be read with assay method, season, clinical risk, and the reason for testing. Raising one number is not the goal of treatment.

Useful question

Will the result change a decision we need to make now?

Misleading target

Trying to push the value as high as possible without an indication.

Clinical context

Bone health, absorption, kidney function, and medicines change interpretation.

Is more better for immunity, heart disease, or cancer?

Low vitamin D levels are associated with many chronic diseases. Yet illness, inactivity, obesity, poor diet, or spending less time outdoors can themselves lower vitamin D. An observational association does not mean supplementation will prevent the disease.

Large randomized trials have not shown that high-dose vitamin D meaningfully reduces cancer, cardiovascular disease, or fractures in generally healthy adults not selected for deficiency. This does not argue against treating deficiency; it shows why deficiency treatment and high-dose disease prevention in healthy people must be separated.

Why are high doses not harmless?

The adult tolerable upper intake level is generally 4,000 IU/day. This is not a target; it marks an upper level unlikely to pose risk for most healthy people. Different short-term doses may be prescribed for deficiency. Because vitamin D appears in many products, total intake can rise unnoticed.

Vitamin D is fat soluble, and excessive intake can cause hypercalcaemia. Nausea, vomiting, weakness, excessive thirst, frequent urination, kidney stones, kidney injury, and rhythm problems can occur. A monthly megadose may sound convenient, but guidelines prefer lower daily dosing to intermittent high doses for many adults who need supplementation.

A practical and safer approach

Start by assessing risk and total intake. Increasing dietary sources may help, but prolonged unprotected sun exposure should not be prescribed to obtain vitamin D. Skin-cancer prevention principles still apply.

If supplementing, record the IU or microgram amount, vitamin D in other products, and duration; 1 microgram equals 40 IU. With confirmed deficiency, investigate the underlying cause as well. Successful treatment concerns safety and clinical purpose, not only a laboratory number.

Take-home message

Vitamin D matters; unnecessary high dosing is wrong not because the vitamin is unimportant, but because the dose is unnecessary.

Supplementation can be important and necessary for people with deficiency or clear risk factors. In healthy low-risk adults, additional benefit from routine testing and high doses has not been established. The right approach is to individualize the reason, dose, duration, and follow-up rather than give everyone the same prescription.

Scientific sources

  1. NIH Office of Dietary Supplements. Vitamin D: Fact Sheet for Health Professionals. Updated 2025.
  2. Demay MB, et al. Vitamin D for the Prevention of Disease: An Endocrine Society Clinical Practice Guideline. Journal of Clinical Endocrinology & Metabolism, 2024.
  3. LeBoff MS, et al. Supplemental Vitamin D and Incident Fractures in Midlife and Older Adults. New England Journal of Medicine, 2022.
  4. Manson JE, et al. Vitamin D Supplements and Prevention of Cancer and Cardiovascular Disease. New England Journal of Medicine, 2019.